tradingkey.logo

Alpha Teknova Inc

TKNO
查看詳細走勢圖
4.460USD
-0.190-4.09%
收盤 12/22, 16:00美東報價延遲15分鐘
238.72M總市值
虧損本益比TTM

Alpha Teknova Inc

4.460
-0.190-4.09%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-4.09%

5天

-2.83%

1月

+3.72%

6月

-19.78%

今年開始到現在

-46.59%

1年

-42.30%

查看詳細走勢圖

TradingKey Alpha Teknova Inc股票評分

單位: USD 更新時間: 2025-12-22

操作建議

Alpha Teknova Inc當前公司基本面數據相對健康,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名94/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價9.00。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Alpha Teknova Inc評分

相關信息

行業排名
94 / 208
全市場排名
223 / 4578
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 6 分析師
買入
評級
9.000
目標均價
+96.51%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Alpha Teknova Inc亮點

亮點風險
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
業績增長期
公司處於發展階段,最新年度總收入37.74M美元
估值低估
公司最新PE估值-13.37,處於3年歷史低位
機構減倉
最新機構持股45.32M股,環比減少3.55%
景順投資公司持倉
明星投資者景順投資公司持倉,最新持倉5.03K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.20

Alpha Teknova Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Alpha Teknova Inc簡介

Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
公司代碼TKNO
公司Alpha Teknova Inc
CEOGunstream (Stephen)
網址https://www.teknova.com/

常見問題

Alpha Teknova Inc(TKNO)的當前股價是多少?

Alpha Teknova Inc(TKNO)的當前股價是 4.460。

Alpha Teknova Inc 的股票代碼是什麼?

Alpha Teknova Inc的股票代碼是TKNO。

Alpha Teknova Inc股票的52週最高點是多少?

Alpha Teknova Inc股票的52週最高點是10.370。

Alpha Teknova Inc股票的52週最低點是多少?

Alpha Teknova Inc股票的52週最低點是3.940。

Alpha Teknova Inc的市值是多少?

Alpha Teknova Inc的市值是238.72M。

Alpha Teknova Inc的淨利潤是多少?

Alpha Teknova Inc的淨利潤為-26.75M。

現在Alpha Teknova Inc(TKNO)的股票是買入、持有還是賣出?

根據分析師評級,Alpha Teknova Inc(TKNO)的總體評級為買入,目標價格為9.000。

Alpha Teknova Inc(TKNO)股票的每股收益(EPS TTM)是多少

Alpha Teknova Inc(TKNO)股票的每股收益(EPS TTM)是-0.334。
KeyAI